Home/Filings/4/0002081169-26-000002
4//SEC Filing

Apel Daniel Joseph 4

Accession 0002081169-26-000002

CIK 0000879407other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 6:45 PM ET

Size

5.2 KB

Accession

0002081169-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-06
Apel Daniel Joseph
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2026-01-06+75,000176,200 total
Footnotes (2)
  • [F1]Represents shares underlying restricted stock units which will vest in four equal annual installments.
  • [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.

Issuer

ARROWHEAD PHARMACEUTICALS, INC.

CIK 0000879407

Entity typeother

Related Parties

1
  • filerCIK 0002081169

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:45 PM ET
Size
5.2 KB